MORGAN STANLEY - KAZIA THERAPEUTICS LTD ownership

KAZIA THERAPEUTICS LTD's ticker is KZIA and the CUSIP is 48669G105. A total of 13 filers reported holding KAZIA THERAPEUTICS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of KAZIA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$189,038
-20.3%
189,950
-7.1%
0.00%
Q2 2023$237,278
+15.5%
204,550
+2.6%
0.00%
Q1 2023$205,453
+29.8%
199,450
-22.5%
0.00%
Q4 2022$158,239
-29.4%
257,341
+25.9%
0.00%
Q3 2022$224,000
-73.5%
204,450
+1.4%
0.00%
Q2 2022$846,000
-62.6%
201,605
-31.3%
0.00%
Q1 2022$2,262,000
-10.3%
293,376
-2.0%
0.00%
Q4 2021$2,521,000
-22.5%
299,426
+4.2%
0.00%
Q3 2021$3,253,000
+41.0%
287,346
+22.8%
0.00%
Q2 2021$2,307,000
-19.4%
233,953
+1.4%
0.00%
Q1 2021$2,862,000
+84.5%
230,801
+28.5%
0.00%
Q4 2020$1,551,000
+52.4%
179,600
+19.0%
0.00%
Q3 2020$1,018,000
+186.8%
150,900
+44.1%
0.00%
Q2 2020$355,000
+54.3%
104,700
+32.0%
0.00%
Q1 2020$230,000
-27.9%
79,303
+8.0%
0.00%
Q4 2019$319,000
+27.1%
73,403
+9.6%
0.00%
Q3 2019$251,000
+59.9%
67,003
+3.4%
0.00%
Q2 2019$157,000
-25.2%
64,806
+2.8%
0.00%
Q1 2019$210,000
+40.9%
63,017
+2.8%
0.00%
Q4 2018$149,000
-22.4%
61,319
+1.8%
0.00%
Q3 2018$192,000
+16.4%
60,233
+7.9%
0.00%
Q2 2018$165,000
-41.3%
55,837
+11.7%
0.00%
Q1 2018$281,000
+92.5%
50,001
+8.7%
0.00%
Q4 2017$146,00046,0010.00%
Other shareholders
KAZIA THERAPEUTICS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Atom Investors LP 99,180$857,0000.09%
HighPoint Advisor Group LLC 32,435$368,0000.04%
Transform Wealth, LLC 106,245$95,0000.02%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 19,600$170,0000.00%
Renaissance Technologies 79,625$688,0000.00%
TRUIST FINANCIAL CORP 35,260$304,0000.00%
UBS Group AG 2,851$25,0000.00%
BREWIN DOLPHIN LTD 32$2760.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 2,800$24,0000.00%
View complete list of KAZIA THERAPEUTICS LTD shareholders